Michael Medinger
- Hematology top 1%
- Hematopoietic Stem Cell Transplantation 40
- Acute Myeloid Leukemia Research 23
- Chronic Myeloid Leukemia Treatments 10
- Multiple Myeloma Research and Treatments 9
- Transplantation top 5%
- Genetics top 5%
- Myeloproliferative Neoplasms: Diagnosis and Treatment 9
- Oncology top 5%
- Cancer Treatment and Pharmacology 14
- Cancer Research top 5%
-
- Angiogenesis and VEGF in Cancer 18
-
- Acute Lymphoblastic Leukemia research 10
- Co-authors
- Jakob PasswegJoachim DrevsClemens UngerK. MrossDominik HeimClaudia LengerkeAlexandar TzankovJörg Halter
- Cited by
- HematologyTransplantationGenetics
- Journals
- Bone Marrow Transplantation (15 papers)Journal of Clinical Oncology (9 papers)Annals of Hematology (6 papers)
- Partner nations
- SwitzerlandGermanyChile
In The Last Decade
Michael Medinger
102 papers receiving 2.2k citations
Peers
Comparison fields: 5 of 109
- Hematology 727
- Transplantation 82
- Genetics 288
- Oncology 739
- Cancer Research 311
Countries citing papers authored by Michael Medinger
This map shows the geographic impact of Michael Medinger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Medinger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Medinger more than expected).
Fields of papers citing papers by Michael Medinger
This network shows the impact of papers produced by Michael Medinger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Medinger. The network helps show where Michael Medinger may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Michael Medinger, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 1 | |
| 3 | 2023 | 4 | |
| 4 | 2023 | 5 | |
| 5 | 2022 | 4 | |
| 6 | 2022 | 6 | |
| 7 | 2022 | 16 | |
| 8 | 2022 | 0 | |
| 9 | 2020 | 10 | |
| 10 | 2020 | 12 | |
| 11 | 2019 | 22 | |
| 12 | 2018 | 39 | |
| 13 | 2018 | 1 | |
| 14 | 2017 | 17 | |
| 15 | 2016 | 29 | |
| 16 | 2015 | 25 | |
| 17 | 2015 | 9 | |
| 18 | 2011 | 2 | |
| 19 | 2010 | 13 | |
| 20 | Antitumor and antiangiogenic activity of cediranib in a preclinical model of renal cell carcinoma. | 2009 | 15 |
About Michael Medinger
Michael Medinger is a scholar working on Hematology, Transplantation and Oncology, having authored 106 papers that have together received 2.3k indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (40 papers), Acute Myeloid Leukemia Research (23 papers), Angiogenesis and VEGF in Cancer (18 papers), Cancer Treatment and Pharmacology (14 papers), Chronic Myeloid Leukemia Treatments (10 papers), Acute Lymphoblastic Leukemia research (10 papers), Multiple Myeloma Research and Treatments (9 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (9 papers). The work is most often cited by research in Hematology (727 citations), Transplantation (82 citations) and Genetics (288 citations). Michael Medinger has collaborated with scholars based in Switzerland, Germany and Chile. Frequent co-authors include Jakob Passweg, Joachim Drevs, Clemens Unger, K. Mross, Dominik Heim, Claudia Lengerke, Alexandar Tzankov, Jörg Halter, Ute Zirrgiebel and Ralph Strecker. Their work appears in journals such as Bone Marrow Transplantation, Journal of Clinical Oncology, Annals of Hematology, Blood and Leukemia Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.